bpc 157 fda classification BPC-157 Before the FDA: Briefing Document Focuses on… FDA July 2026 Peptide Meeting:
Description
Cell 155 , 16241638 (2013)

BPC-157 has a half-life of roughly 4 to 6 hours, but the cellular repair processes it triggers continue well beyond that window

By mimicking the GLP-1 hormone, it stimulates insulin secretion

If the BMI has dropped below the payer threshold during treatment, continued coverage may require additional documentation showing that discontinuation would likely result in weight regain
Used under medical supervision, with pharmacy-sourced compounds and proper protocols, reported side effects are generally mild
